These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1368965)

  • 21. Membrane lipids determine the antibiotic activity of the lantibiotic gallidermin.
    Christ K; Al-Kaddah S; Wiedemann I; Rattay B; Sahl HG; Bendas G
    J Membr Biol; 2008; 226(1-3):9-16. PubMed ID: 19009315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of nisin Z production in Lactococcus lactis BFE 1500 isolated from wara, a traditional Nigerian cheese product.
    Olasupo NA; Schillinger U; Narbad A; Dodd H; Holzapfel WH
    Int J Food Microbiol; 1999 Dec; 53(2-3):141-52. PubMed ID: 10634705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
    Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
    Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SpaC and NisC, the cyclases involved in subtilin and nisin biosynthesis, are zinc proteins.
    Okeley NM; Paul M; Stasser JP; Blackburn N; van der Donk WA
    Biochemistry; 2003 Nov; 42(46):13613-24. PubMed ID: 14622008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery.
    van Heel AJ; Kloosterman TG; Montalban-Lopez M; Deng J; Plat A; Baudu B; Hendriks D; Moll GN; Kuipers OP
    ACS Synth Biol; 2016 Oct; 5(10):1146-1154. PubMed ID: 27294279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lantibiotic resistance.
    Draper LA; Cotter PD; Hill C; Ross RP
    Microbiol Mol Biol Rev; 2015 Jun; 79(2):171-91. PubMed ID: 25787977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles.
    Driessen AJ; van den Hooven HW; Kuiper W; van de Kamp M; Sahl HG; Konings RN; Konings WN
    Biochemistry; 1995 Feb; 34(5):1606-14. PubMed ID: 7849020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual role of GdmH in producer immunity and secretion of the Staphylococcal lantibiotics gallidermin and epidermin.
    Hille M; Kies S; Götz F; Peschel A
    Appl Environ Microbiol; 2001 Mar; 67(3):1380-3. PubMed ID: 11229936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bacteriocins of ruminal bacteria and their potential as an alternative to antibiotics.
    Russell JB; Mantovani HC
    J Mol Microbiol Biotechnol; 2002 Jul; 4(4):347-55. PubMed ID: 12125815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin.
    Sahl HG; Grossgarten M; Widger WR; Cramer WA; Brandis H
    Antimicrob Agents Chemother; 1985 May; 27(5):836-40. PubMed ID: 4015073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Separation and determination of closely related lantibiotics by micellar electrokinetic chromatography.
    Stanley B; Mehr KA; Kellock T; Van Hamme JD; Donkor KK
    J Sep Sci; 2009 Sep; 32(17):2993-3000. PubMed ID: 19639549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening and characterization of novel bacteriocins from lactic acid bacteria.
    Zendo T
    Biosci Biotechnol Biochem; 2013; 77(5):893-9. PubMed ID: 23649268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kunkecin A, a New Nisin Variant Bacteriocin Produced by the Fructophilic Lactic Acid Bacterium,
    Zendo T; Ohashi C; Maeno S; Piao X; Salminen S; Sonomoto K; Endo A
    Front Microbiol; 2020; 11():571903. PubMed ID: 33042078
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antibacterial metabolites of lactic acid bacteria: their diversity and properties].
    Stoianova LG; Ustiugova EA; Netrusov AI
    Prikl Biokhim Mikrobiol; 2012; 48(3):259-75. PubMed ID: 22834296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nano-engineering the Antimicrobial Spectrum of Lantibiotics: Activity of Nisin against Gram Negative Bacteria.
    Vukomanović M; Žunič V; Kunej Š; Jančar B; Jeverica S; Podlipec R; Suvorov D
    Sci Rep; 2017 Jun; 7(1):4324. PubMed ID: 28659619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.
    Carroll J; Draper LA; O'Connor PM; Coffey A; Hill C; Ross RP; Cotter PD; O'Mahony J
    Int J Antimicrob Agents; 2010 Aug; 36(2):132-6. PubMed ID: 20547041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics.
    Brötz H; Josten M; Wiedemann I; Schneider U; Götz F; Bierbaum G; Sahl HG
    Mol Microbiol; 1998 Oct; 30(2):317-27. PubMed ID: 9791177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lantibiotics].
    Israil A
    Bacteriol Virusol Parazitol Epidemiol; 1992; 37(3-4):1-8. PubMed ID: 1340251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response relationships. A model for describing interactions, and its application to the combined effect of nisin and lactic acid on Leuconostoc mesenteroides.
    Cabo ML; Murado MA; González MP; Pastoriza L
    J Appl Microbiol; 2000 May; 88(5):756-63. PubMed ID: 10792535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo cluster formation of nisin and lipid II is correlated with membrane depolarization.
    Tol MB; Morales Angeles D; Scheffers DJ
    Antimicrob Agents Chemother; 2015; 59(6):3683-6. PubMed ID: 25870072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.